Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Gunawardana, Manjula ^a   Mullen, Madeline ^a   Moss, John A ^a   Pyles, Richard B ^b   Nusbaum, Rebecca J ^b   Patel, Jignesh ^b   Vincent, Kathleen L ^b   Wang, Charles ^c   Guo, Chao ^c   Yuan, Yate Ching ^c   Warden, Charles D ^c   Baum, Marc M ^a  

^a OAK CREST INSTITUTE OF SCIENCE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN; MEMBRANE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ABCB1 GENE; ABCB2 GENE; ABCB3 GENE; ABCB4 GENE; ABCC1 GENE; ABCG2 GENE; ACTB GENE; ADULT; ARTICLE; B2M GENE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; FEMALE; FEMALE GENITAL SYSTEM; GAPDH GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOLOCALIZATION; MEMBRANE TRANSPORT; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; RHCG GENE; RNA EXTRACTION; SLC16A12 GENE; SLC16A3 GENE; SLC22A18 GENE; SLC24A3 GENE; SLC2A1 GENE; SLC35E1 GENE; SLC35E4 GENE; SLC38A10 GENE; SLC44A1 GENE; SLC6A9 GENE; SLCA6 GENE; SLCA9 GENE; TAP1 GENE;

ADULT; CHEMOPREVENTION; FEMALE; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; VAGINA; YOUNG ADULT;

EID: 84885450494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077340     Document Type: Article

References (50)

1. Hecht R, Stover J, Bollinger L, Muhib F, Case K, et al. (2010) Financing of HIV/AIDS Programme Scale-up in Low-income and Middle-income Countries, 2009-31. Lancet 376: 1254-1260. doi:10.1016/S0140-6736(10)61255-X. PubMed: 20934597.
2. Shattock RJ, Warren M, McCormack S, Hankins CA, (2011) Turning the Tide Against HIV. Science 333: 42-43. doi:10.1126/science.1206399. PubMed: 21719662.
3. Cohen MS, Gay C, Kashuba ADM, Blower S, Paxton L, (2007) Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1. Ann Intern Med 146: 591-U563. doi:10.7326/0003-4819-146-8-200704170-00010. PubMed: 17438318.
4. Masse PJ, Shattock R, Moore JP, (2008) Antiretroviral Drug-based Microbicides to Prevent HIV-1 Sexual Transmission. Annu Rev Med 59: 455-471. doi:10.1146/annurev.med.59.061206.112737. PubMed: 17892435.
5. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science 329: 1168-1174. doi:10.1126/science.1193748. PubMed: 20643915.
6. Karim SSA, Karim QA, (2011) Antiretroviral Prophylaxis: a Defining Moment in HIV Control. Lancet 378: E23-E25. doi:10.1016/S0140-6736(11)61136-7. PubMed: 21771566.
7. Padian NS, McCoy SI, Karim SSA, Hasen N, Kim J, et al. (2011) HIV Prevention Transformed: the New Prevention Research Agenda. Lancet 378: 269-278. doi:10.1016/S0140-6736(11)60877-5. PubMed: 21763938.
8. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. (2012) Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N Engl J Med 367: 399-410. doi:10.1056/NEJMoa1108524. PubMed: 22784037.
9. Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba ADM, (2012) Antiviral Agents and HIV Prevention: Controversies, Conflicts, and Consensus. AIDS 26: 1585-1598. doi:10.1097/QAD.0b013e3283543e83. PubMed: 22507927.
10. Hendrix CW, Cao YJ, Fuchs EJ, (2009) Topical Microbicides to Prevent HIV: Clinical Drug Development Challenges. Annu Rev Pharmacol Toxicol 49: 349-375. doi:10.1146/annurev.pharmtox.48.113006.094906. PubMed: 19006450.
11. Karim SSA, Kashuba ADM, Werner L, Karim QA, (2011) Drug Concentrations After Topical and Oral Antiretroviral Pre-exposure Prophylaxis: Implications for HIV Prevention in Women. Lancet 378: 279-281. doi:10.1016/S0140-6736(11)60878-7. PubMed: 21763939.
12. Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, et al. (2011) Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission. Sci Transl Med 3: 112re4. PubMed: 22158861.
13. Kis O, Robillard K, Chan GNY, Bendayan R, (2010) The Complexities of Antiretroviral Drug-drug Interactions: Role of ABC and SLC Transporters. Trends Pharmacol Sci 31: 22-35. doi:10.1016/j.tips.2009.10.001. PubMed: 20004485.
14. Ford J, Khoo SH, Back DJ, (2004) The Intracellular Pharmacology of Antiretroviral Protease Inhibitors. J Antimicrob Chemother 54: 982-990. doi:10.1093/jac/dkh487. PubMed: 15537695.
15. Kim RB, (2003) Drug Transporters in HIV Therapy. Top HIV Med 11: 136-139. PubMed: 12876331.
16. Brown KC, Paul S, Kashuba ADM, (2009) Drug Interactions with New and Investigational Antiretrovirals. Clin Pharmacokinet 48: 211-241. doi:10.2165/00003088-200948040-00001. PubMed: 19492868.
17. Dickinson L, Khoo S, Back D, (2010) Pharmacokinetics and Drug-drug Interactions of Antiretrovirals: an Update. Antiviral Res 85: 176-189. doi:10.1016/j.antiviral.2009.07.017. PubMed: 19665485.
18. Maffeo A, Bellomi E, Solimeo I, Bambacioni F, Scagnolari C, et al. (2004) P-glycoprotein Expression Affects the Intracellular Concentration and Antiviral Activity of the Protease Inhibitor Saquinavir in a T Cell Line. Microbiologica 27: 119-126. PubMed: 15646074.
19. Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, et al. (2010) Coexistence of Passive and Carrier-mediated Processes in Drug Transport. Nat Rev Drug Discov 9: 597-614. doi:10.1038/nrd3187. PubMed: 20671764.
20. R Development Core Team (2013) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
21. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc B Stat Methodol 57: 289-300.
22. Kuchiiwa TKT, Nio-Kobayashi J, Takahashi-Iwanaga H, Yajima T, Iwanaga T, (2011) Cellular Expression of Monocarboxylate Transporters in the Female Reproductive Organ of Mice: Implications for the Genital Lactate Shuttle. Histochem Cell Biol 135: 351-360. doi:10.1007/s00418-011-0794-2. PubMed: 21360229.
23. Liu X, Yu X, Zack DJ, Zhu H, Qian J, (2008) TiGER: A Database for Tissue-specific Gene Expression and Regulation. BMC Bioinformatics 9: 271. doi:10.1186/1471-2105-9-271. PubMed: 18541026.
24. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, et al. (2006) Rat Toxicogenomic Study Reveals Analytical Consistency across Microarray Platforms. Nat Biotechnol 24: 1162-1169. doi:10.1038/nbt1238. PubMed: 17061323.
25. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, et al. (2006) Performance Comparison of One-color and Two-color Platforms within the MicroArray Quality Control (MAQC) Project. Nat Biotechnol 24: 1140-1150. doi:10.1038/nbt1242. PubMed: 16964228.
26. Shi LM, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The MicroArray Quality Control (MAQC) Project Shows Inter- and Intraplatform Reproducibility of Gene Expression Measurements. Nat Biotechnol 24: 1151-1161. doi:10.1038/nbt1239. PubMed: 16964229.
27. Shi LM, Jones WD, Jensen RV, Harris SC, Perkins RG, et al. (2008) The Balance of Reproducibility, Sensitivity, and Specificity of Lists of Differentially Expressed Genes in Microarray Studies. BMC Bioinformatics 9: S10. doi:10.1186/1471-2105-9-S7-P10. PubMed: 18793455.
28. Mao SH, Wang C, Dong G, (2009) Evaluation of Inter-laboratory and Cross-platform Concordance of DNA Microarrays through Discriminating Genes and Classifier Transferability. J Bioinform Comput Biol 7: 157-173. doi:10.1142/S0219720009004011. PubMed: 19226665.
29. Smith CJ, Osborn AM, (2009) Advantages and Limitations of Quantitative PCR (Q-PCR)-based Approaches in Microbial Ecology. FEMS Microbiol Ecol 67: 6-20. doi:10.1111/j.1574-6941.2008.00629.x. PubMed: 19120456.
30. (1978) The Human Vagina: Hafez ESE, Evans TN, eds. New York: Elsevier. p. pp. 515.
31. Robboy SJ, Prade M, Cunha G, (1992) Histology for Pathologists. In: Sternberg SS, eds. North Holland, New York: Raven Press.
32. Anderle P, Huang Y, Sadée W, (2004) Intestinal Membrane Transport of Drugs and Nutrients: Genomics of Membrane Transporters Using Expression Microarrays. Eur J Pharm Sci 21: 17-24. doi:10.1016/S0928-0987(03)00169-6. PubMed: 14706809.
33. Savas JN, Stein BD, Wu CC, Yates JR, (2011) Mass Spectrometry Accelerates Membrane Protein Analysis. Trends Biochem_Sci 36: 388-396. PubMed: 21616670.
34. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L, (2005) Innate and Adaptive Immunity in Female Genital Tract: Cellular Responses and Interactions. Immunol Rev 206: 306-335. doi:10.1111/j.0105-2896.2005.00287.x. PubMed: 16048557.
35. Hu JJ, Gardner MB, Miller CJ, (2000) Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells. J Virol 74: 6087-6095. doi:10.1128/JVI.74.13.6087-6095.2000. PubMed: 10846092.
36. Zhang ZQ, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, et al. (1999) Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4(+) T Cells. Science 286: 1353-1357. doi:10.1126/science.286.5443.1353. PubMed: 10558989.
37. Miller CJ, Li QS, Abel K, Kim EY, Ma ZM, et al. (2005) Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency Virus. J Virol 79: 9217-9227. doi:10.1128/JVI.79.14.9217-9227.2005. PubMed: 15994816.
38. Haase AT, (2010) Targeting Early Infection to Prevent HIV-1 Mucosal Transmission. Nature 464: 217-223. doi:10.1038/nature08757. PubMed: 20220840.
39. Parikh UM, Dobard C, Sharma S, Cong ME, Jia HW, et al. (2009) Complete Protection from Repeated Vaginal Simian-human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine. J Virol 83: 10358-10365. doi:10.1128/JVI.01073-09. PubMed: 19656878.
40. Veazey RS, Ketas TJ, Dufour J, Moroney-Rasmussen T, Green LC, et al. (2010) Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV-1 Entry via the CCR5 Co-Receptor. J Infect Dis 202: 739-744. doi:10.1086/655661. PubMed: 20629537.
41. Ray AS, Cihlar T, Robinson KL, Tong L, Vela JE, et al. (2006) Mechanism of Active Renal Tubular Efflux of Tenofovir. Antimicrob Agents Chemother 50: 3297-3304. doi:10.1128/AAC.00251-06. PubMed: 17005808.
42. Uwai Y, Ida H, Tsuji Y, Katsura T, Inui K, (2007) Renal Transport of Adefovir, Cidofovir, and Tenofovir by SLC22A Family Members (hOAT1, hOAT3, and hOCT2). Pharm Res 24: 811-815. doi:10.1007/s11095-006-9196-x. PubMed: 17372702.
43. Anderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, et al. (2011) Pharmacological Considerations for Tenofovir and Emtricitabine to Prevent HIV Infection. J Antimicrob Chemother 66: 240-250. doi:10.1093/jac/dkq447. PubMed: 21118913.
44. Moss JA, Baum MM, Malone AM, Kennedy S, Kopin E, et al. (2012) Tenofovir and Tenofovir Disoproxil Pharmacokinetics from Intravaginal Rings. AIDS 26: 707-710. doi:10.1097/QAD.0b013e3283509abb. PubMed: 22210639.
45. Anand BS, Hill JM, Dey S, Maruyama K, Bhattacharjee PS, et al. (2003) In vivo Antiviral Efficacy of a Dipeptide Acyclovir Prodrug, Val-val-acyclovir, Against HSV-1 Epithelial and Stromal Keratitis in the Rabbit Eye Model. Invest Ophthalmol Vis Sci 44: 2529-2534. doi:10.1167/iovs.02-1251. PubMed: 12766053.
46. Anand BS, Katragadda S, Nashed YE, Mitra AK, (2004) Amino Acid Prodrugs of Acyclovir as Possible Antiviral Agents Against Ocular HSV-1 Infections: Interactions with the Neutral and Cationic Amino Acid Transporter on the Corneal Epithelium. Curr Eye Res 29: 153-166. doi:10.1080/02713680490504614. PubMed: 15512962.
47. Jain R, Agarwal S, Majumdar S, Zhu XD, Pal D, et al. (2005) Evasion of P-gp Mediated Cellular Efflux and Permeability Enhancement of HIV-protease Inhibitor Saquinavir by Prodrug Modification. Int J Pharm 303: 8-19. doi:10.1016/j.ijpharm.2005.06.017. PubMed: 16137847.
48. Janoria KG, Boddu SHS, Natesan S, Mitra AK, (2010) Vitreal Pharmacokinetics of Peptide-transporter-targeted Prodrugs of Ganciclovir in Conscious Animals. J Ocul Pharmacol Ther 26: 265-271. doi:10.1089/jop.2009.0123. PubMed: 20565313.
49. GeneCards website. Available: http://www.genecards.org. Accessed 2013 Feb 15.
50. HUGO Gene Nomenclature Committee website. Available: http://www.genenames.org. Accessed 2013 Feb 15.